Dr Emma Rebecca Pinkston, PHARMD in Allen, TX - Pharmacist

Dr Emma Rebecca Pinkston, PHARMD is a Pharmacist based in Allen, Texas. Dr Emma Rebecca Pinkston is licensed to practice in Texas (license number 40075) and her current practice location is 150 E Stacy Rd, T-2516, Allen, Texas. She can be reached at her office (for appointments etc.) via phone at (469) 342-2005.

NPI number for Dr Emma Rebecca Pinkston is 1164717294 and her current mailing address is 150 E Stacy Rd, Allen, Texas. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1164717294.

Contact Information

	Dr Emma Rebecca Pinkston, PHARMD
	150 E Stacy Rd, T-2516, Allen, TX 75002-8756
	(469) 342-2005
	(469) 342-2015

Healthcare Provider's Profile

Full Name	Dr Emma Rebecca Pinkston
Gender	Female
Speciality	Pharmacist
Location	150 E Stacy Rd, Allen, Texas
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1164717294
Provider Enumeration Date: 06/16/2011
Last Update Date: 06/16/2011

Medical Identifiers

Medical identifiers for Dr Emma Rebecca Pinkston such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1164717294	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	40075 (Texas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Emma Rebecca Pinkston is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Emma Rebecca Pinkston, PHARMD 150 E Stacy Rd, Allen, TX 75002-8756 Ph: (469) 342-2005	Dr Emma Rebecca Pinkston, PHARMD 150 E Stacy Rd, T-2516, Allen, TX 75002-8756 Ph: (469) 342-2005

News Archive

Recent rituximab trial with TNF inhibitors reports no new safety risks in patients with RA

A recent trial of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis found the safety profile to be consistent with other RA trials with TNF inhibitors.

Merck Serono to present Erbitux data at ESMO Congress

Merck Serono, a division of Merck KGaA, Darmstadt, Germany announces today that it will be presenting new data from several studies of Erbitux (cetuximab) in a range of solid tumor types including the first Phase II data in breast and prostate cancers. These data will be presented at the forthcoming 35th European Society for Medical Oncology Congress (ESMO) in Milan, October 8-12, 2010.

Advances in epigenome sequencing technologies can allow comprehensive analysis of cancers

An international research collaboration led by UCL scientists has developed ways to improve the quality and accuracy of information harvested from epigenome sequencing datasets in two new research papers published jointly in Nature Biotechnology and Nature Communications today. According to the studies, epigenome sequencing technologies can allow for more comprehensive analysis of cancers - a key component in the development of targeted approaches to combat cancer.

Scaling up communication and coordination biggest challenge in GAVI's $1B vaccine initiative

In this post in the Huffington Post's "Impact" blog, Orin Levine, executive director of the International Vaccine Access Center at Johns Hopkins University, responds to the GAVI Alliance's announcement on Tuesday that it will supply more than $1 billion in childhood vaccines to 37 of the world's poorest countries, writing, "As the Alliance takes perhaps the most significant step ever toward increasing access to lifesaving immunization with this new and exciting round of country approvals, the challenge will be to ensure that every piece of the puzzle is in place to deliver on GAVI's tremendous promise."

EMA CHMP recommends marketing authorization for GE's VIZAMYL for PET imaging to detect beta amyloids

GE Healthcare today announced the receipt of a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use. This opinion recommends the granting of a marketing authorisation for VIZAMYL (Flutemetamol F18 injection), a radiopharmaceutical medicinal product indicated for Positron Emission Tomography imaging of beta amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease and other causes of cognitive impairment.

Pharmacist in Allen, TX

James Randy Viator, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5205 Eastgate Ln, Allen, TX 75002 Phone: 972-442-0563 Fax: 860-754-0910
Samreen Asif, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1997 Cousins Trl, Allen, TX 75013 Phone: 410-733-1052
Paul M Mekaowulu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1504 Riverdale Dr, Allen, TX 75013 Phone: 214-383-6660
Asten Floyd, RPH, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1819 E Bethany Dr, Allen, TX 75002 Phone: 972-359-2884
Dr. Shelly Hartley, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1520 E Exchange Pkwy, Allen, TX 75002 Phone: 214-547-8671 Fax: 214-547-9952
Ms. Dana Dang Bui, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 510 E Main St, Allen, TX 75002 Phone: 972-727-6509
Joel Gibson, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 510 E Main St, Allen, TX 75002 Phone: 972-727-6509

Dr Emma Rebecca Pinkston, PHARMD - Pharmacist in Allen, TX